IVI RMA North America, a leader in fertility care and assisted reproduction, has announced a partnership with TMRW Life Sciences to implement digital management and storage systems for frozen eggs, embryos, and sperm across its network of clinics.
The partnership will involve the deployment of TMRW’s FDA-cleared digital specimen management technology across IVI RMA North America’s 22+ IVF laboratories, serving tens of thousands of patients. The system will be used for both onsite storage at clinics and offsite storage at TMRW’s biorepositories.
“As a network driven by patient care and innovation, we are proud to establish this long-term partnership with TMRW Life Sciences and provide our patients with the most advanced storage solutions available,” said Dr. Thomas Molinaro, Chief Medical Officer of IVI RMA North America. “Since our founding, IVI RMA North America has been singularly focused on delivering exceptional results for our patients and driving the industry forward through research and use of cutting-edge technology. Our partnership with TMRW Life Sciences aligns perfectly with this mission.”
Several IVI RMA North America clinics have already begun implementing TMRW’s digital specimen management system for both existing specimen inventories and new patient specimens. The partnership builds on previous positive experiences from Conceptions Reproductive Associates of Colorado and the Boston IVF network, which were long-time TMRW partners before becoming part of the IVI RMA North America network. The digital upgrade will enhance standardization, scalability, and visibility across the network, with a significant reduction in the risks of error, mix-up, and loss of specimens.
“TMRW and IVI RMA North America are both innovative, tech-forward leaders in a rapidly growing and evolving fertility industry, and we’re thrilled about the impact this partnership will bring,” said Louis Villalba, CEO of TMRW. “With an exciting year ahead—supporting more clinics, reaching more patients, and introducing our next-generation storage systems—together with IVI RMA we are setting a new standard of care.”
Founded in 2018, TMRW Life Sciences developed the first automated platform for safe management and storage of frozen reproductive specimens. Their technology enables digital identification and tracking of specimens, automated robotics for specimen handling, and 24/7 remote monitoring. According to TMRW, their technology platforms reduce potential points of failure by 94% compared to manual systems, helping to minimize the risk of specimen mix-up, damage, or loss.
